Connective tissue growth factor (CTGF) regulates the fusion of osteoclast precursors by inhibiting Bcl6 in periodontitis
Open Access
- 1 January 2020
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 17 (5) , 647-656
Abstract
Connective tissue growth factor (CTGF), an extracellular matrix protein with various biological functions, is known to be upregulated in multiple chronic diseases such as liver fibrosis and congestive heart failure, but the mechanism it undertakes to cause alveolar bone loss in periodontitis remains elusive. The present study therefore investigates the pathways involving CTGF in chronic periodontitis. RNA sequencing revealed a notable increase in the expression of CTGF in chronic periodontitis tissues. Also, TRAP staining, TRAP activity and bone resorption assays showed that osteoclast formation and function is significantly facilitated in CTGF-treated bone marrow-derived macrophages (BMMs). Interestingly, western blotting and immunofluorescence staining results displayed that CTGF had little effect on the osteoclastogenic differentiation mediated by the positive regulators of osteoclastogenesis such as nuclear factor of activated T cells 1 (NFATc1). However, following results showed that both the mRNA and protein expressions of B cell lymphoma 6 (Bcl6), a transcriptional repressor of “osteoclastic” genes, were significantly downregulated by CTGF treatment. Moreover, CTGF upregulated the expressions of v-ATPase V0 subunit d2 (ATP6v0d2) and Dendritic cell-specific transmembrane protein (DC-STAMP) which are osteoclastic genes specifically required for osteoclast cell-cell fusion in pre-osteoclasts. Findings from this study suggest that CTGF promotes the fusion of pre-osteoclasts by downregulating Bcl6 and subsequently increasing the expression of DC-STAMP in periodontitis. Understanding this novel mechanism that leads to increased osteoclastogenesis in periodontitis may be employed for the development of new therapeutic targets for preventing periodontitis-associated alveolar bone resorption.Keywords
This publication has 42 references indexed in Scilit:
- The Role of Osteoimmunology in Periodontal DiseaseBioMed Research International, 2013
- CCN2: a master regulator of the genesis of bone and cartilageJournal of Cell Communication and Signaling, 2013
- Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)Journal of Bone and Mineral Research, 2011
- Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressorsArthritis Research & Therapy, 2011
- Differential expression analysis for sequence count dataGenome Biology, 2010
- Oxidative Stress, Systemic Inflammation, and Severe PeriodontitisJournal of Dental Research, 2010
- The Blimp1–Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasisJournal of Experimental Medicine, 2010
- Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal diseaseJournal of Oral Microbiology, 2010
- Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritisArthritis Research & Therapy, 2009
- NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubismJournal of Clinical Investigation, 2008